Natixis’s iKang Healthcare Group, Inc. KANG Stock Holding History

Natixis’s Portfolio KANG Stock Details KANG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-100,100	Closed	-$2.05M	–	1036
2018 Q2	$2.05M	Buy	+100,100	New	+$2.02M	0.01%	514

Other funds holding KANG

Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

HIM

Hillhouse Investment Management Grand Cayman, Cayman Islands $3.13B AUM 7.29% 1-Year Est. Return

Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Conning Inc Hartford, Connecticut $3.01B AUM 16.23% 1-Year Est. Return

Natixis's KANG Position: Q3 2018 in Review

Natixis sold out of iKang Healthcare Group, Inc. (KANG) in Q3 2018, closing a stake of 100,100 shares — an estimated $2.05M sold.

Natixis first reported a position in KANG in Q2 2018 and held it in 1 quarter. The position peaked at $2.05M in Q2 2018. 52 funds tracked by Wall St. Rank hold KANG as of Q3 2018.

Natixis reported no remaining iKang Healthcare Group, Inc. position as of Q3 2018 after selling out during the quarter.
Natixis sold 100,100 iKang Healthcare Group, Inc. shares in Q3 2018, an estimated $2.05M.
Natixis first reported a position in iKang Healthcare Group, Inc. in Q2 2018 and held it in 1 quarter.
Natixis's iKang Healthcare Group, Inc. position peaked at $2.05M in Q2 2018.
52 funds tracked by Wall St. Rank held iKang Healthcare Group, Inc. as of Q3 2018.

Based on Natixis's 13F filing for Q3 2018, filed 14 Nov 2018.